BX Swiss TOP 30 CHF
1.360,11
PKT
-11,03
PKT
-0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.12.20 | UBS buy | Goldman Sachs Group Inc. | |
| 15.12.20 | UBS Sector Perform | RBC Capital Markets | |
| 15.12.20 | Nestlé buy | Goldman Sachs Group Inc. | |
| 14.12.20 | Zurich Insurance buy | Kepler Cheuvreux | |
| 14.12.20 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.12.20 | Novartis buy | Jefferies & Company Inc. | |
| 11.12.20 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 11.12.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 11.12.20 | Nestlé buy | Kepler Cheuvreux | |
| 10.12.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 10.12.20 | Swiss Re Outperform | RBC Capital Markets | |
| 10.12.20 | Roche Hold | Kepler Cheuvreux | |
| 10.12.20 | Holcim Hold | Jefferies & Company Inc. | |
| 10.12.20 | Roche buy | Jefferies & Company Inc. | |
| 10.12.20 | Novartis buy | Jefferies & Company Inc. | |
| 09.12.20 | Nestlé Neutral | Credit Suisse Group | |
| 08.12.20 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 08.12.20 | Nestlé buy | Goldman Sachs Group Inc. | |
| 08.12.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 08.12.20 | Givaudan buy | UBS AG | |
| 07.12.20 | Roche overweight | JP Morgan Chase & Co. | |
| 07.12.20 | Holcim Hold | Jefferies & Company Inc. | |
| 03.12.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 03.12.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 02.12.20 | UBS Neutral | UBS AG | |
| 01.12.20 | Givaudan Underperform | Bernstein Research | |
| 30.11.20 | Holcim buy | Goldman Sachs Group Inc. | |
| 30.11.20 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 27.11.20 | Novartis Underweight | Barclays Capital | |
| 25.11.20 | ABB (Asea Brown Boveri) Hold | HSBC | |
| 25.11.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 25.11.20 | Novartis buy | UBS AG | |
| 25.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.11.20 | Swiss Re overweight | Barclays Capital | |
| 23.11.20 | Swiss Re buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.11.20 | UBS overweight | JP Morgan Chase & Co. | |
| 20.11.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 20.11.20 | Swiss Re Outperform | RBC Capital Markets | |
| 20.11.20 | Swiss Re overweight | JP Morgan Chase & Co. |